Multisite Quality Improvement Study of a Patient-Pathologist Consultation Program.


Journal

American journal of clinical pathology
ISSN: 1943-7722
Titre abrégé: Am J Clin Pathol
Pays: England
ID NLM: 0370470

Informations de publication

Date de publication:
18 05 2021
Historique:
pubmed: 29 12 2020
medline: 24 6 2021
entrez: 28 12 2020
Statut: ppublish

Résumé

The aim of this multisite quality improvement study was to evaluate patients' experiences with the patient-centered pathology (PCP) consultation program and to determine whether PCP enhanced their care experience. Patients were invited to attend PCP consultations to review their pathology report and slides and have their questions answered by the pathologist privately, with the option to attend the appointment with family members or friends for support. A patient experience questionnaire (PEQ) was administered to patients, who participated voluntarily in the PCP, and survey data were collected and stored in REDCap. Statistical analysis was performed using SAS 9.4 (SAS Institute). Sixty-seven patients (95.5% female) aged 18 to 84 years across 4 institutions completed the PEQ. Overall, 58% and 15.8% of patients had breast and brain tumors, respectively, and 59.7% of tumors were newly diagnosed. Most patients thought it was important for them to learn as much as they could about their health condition. However, the majority of patients reported some degree of difficulty learning about their health condition based on written information, despite 97% having completed high school and/or further education. The majority of patients rated their pathologist as "excellent" across communication metrics. Ultimately, 100% of respondents were satisfied, found their visits to be useful, and would recommend the PCP to other patients. Patients found that personalized clinical encounters with pathologists improved their understanding of their health condition and their satisfaction with their care experience. Patients thought pathologists communicated respectfully, effectively, and empathetically.

Identifiants

pubmed: 33367493
pii: 6053731
doi: 10.1093/ajcp/aqaa202
pmc: PMC8130872
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

887-894

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR002553
Pays : United States

Informations de copyright

© American Society for Clinical Pathology, 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Arch Pathol Lab Med. 2018 Jun;142(6):682-683
pubmed: 29848029
Arch Pathol Lab Med. 2019 Aug;143(8):917-918
pubmed: 31339753
BMC Med Res Methodol. 2012 Feb 15;12:13
pubmed: 22335801
Arch Pathol Lab Med. 2020 Apr;144(4):490-496
pubmed: 31429605
Soc Sci Med. 2010 Jun;70(12):1882-1887
pubmed: 20382459
Arch Pathol Lab Med. 2019 Jul;143(7):852-858
pubmed: 30398913
J Clin Pathol. 2020 Aug;73(8):454-455
pubmed: 32107281
Arch Pathol Lab Med. 2015 Apr;139(4):441-4
pubmed: 25822761

Auteurs

Rachel Jug (R)

Departments of Pathology, Durham, NC.

Adam L Booth (AL)

Department of Pathology, University of Texas Medical Branch at Galveston.

Anne F Buckley (AF)

Departments of Pathology, Durham, NC.

Jordan Newell (J)

Departments of Pathology, Hershey.

Joshua Kesterson (J)

Gynecologic Oncology, Pennsylvania State University Milton S. Hershey Medical Center, Hershey.

Jerad M Gardner (JM)

Department of Laboratory Medicine, Geisinger Medical Center, Danville, PA.

Lerna Ozcan (L)

Departments of Surgery, Lowell, MA.

Beiyu Liu (B)

Biostatistics and Bioinformatics, Duke Health, Durham, NC.

Cynthia L Green (CL)

Biostatistics and Bioinformatics, Duke Health, Durham, NC.

Lija Joseph (L)

Pathology, Lowell General Hospital, Lowell, MA.

Thomas J Cummings (TJ)

Departments of Pathology, Durham, NC.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH